Aug 28, 2026 06:17AM
Aug 28, 2026 06:17AM
Jul 29, 2026 10:21AM
Jun 18, 2026 04:58PM
Jun 18, 2026 04:56PM
Jun 10, 2026 12:03PM
Jun 10, 2026 12:03PM Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy 
Apr 30, 2026 06:25AM
Apr 29, 2026 03:23PM
Apr 29, 2026 03:23PM
Apr 29, 2026 06:30AM
Apr 29, 2026 06:30AM
Dec 12, 2025 10:47AM
Nov 5, 2025 07:00AM Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS
Jul 30, 2025 07:00AM
May 20, 2025 05:21PM
May 19, 2025 04:52AM
May 20, 2024 08:25PM
May 8, 2024 07:00AM
Feb 25, 2024 08:36PM
Feb 23, 2024 08:15PM Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
Feb 12, 2024 11:21AM
Feb 9, 2024 08:00PM
Jan 31, 2024 07:00AM
Nov 8, 2023 07:00AM
Aug 21, 2023 04:00PM
Aug 21, 2023 04:00PM
Aug 2, 2023 07:00AM Teva Reports Second Quarter 2023 Financial Results
Jul 27, 2023 08:00AM
Jul 24, 2023 06:03AM
Jun 12, 2023 07:00AM
Jun 12, 2023 05:19AM
May 18, 2023 08:30AM
May 18, 2023 07:55AM
May 15, 2023 08:04AM Teva Pharma (TEVA) Announces AUSTEDO XR Now Available in the U.S.
May 15, 2023 08:00AM
May 10, 2023 07:00AM
May 1, 2023 05:25AM
Apr 28, 2023 08:22PM
Apr 28, 2023 07:22PM
Mar 1, 2023 04:11PM
Feb 27, 2023 03:30AM Teva Announces Launch of $2,060,000,000 (Equivalent) Offering of Sustainability-Linked Senior Notes
Feb 8, 2023 07:00AM
Jan 9, 2023 08:02AM
Jan 9, 2023 08:00AM
Jan 6, 2023 07:03AM
Jan 6, 2023 07:00AM
Jan 6, 2023 04:00AM
Dec 22, 2022 04:00AM Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®
Nov 22, 2022 08:31AM

1,186,413 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All